We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

200 hedge funds and large institutions have $2.04B invested in Sage Therapeutics in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 68 increasing their positions, 60 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

259% more call options, than puts

Call options by funds: $23.4M | Put options by funds: $6.52M

24% more capital invested

Capital invested by funds: $1.65B → $2.04B (+$396M)

13% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 60

1.55% more ownership

Funds ownership: 86.31% → 87.86% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 209 → 200 (-9)

23% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 30

Holders
200
Holders Change
-9
Holders Change %
-4.31%
% of All Funds
3.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
68
Reduced
60
Closed
30
Calls
$23.4M
Puts
$6.52M
Net Calls
+$16.9M
Net Calls Change
+$10.2M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$26.9M
2
BlackRock
BlackRock
New York
+$22.4M
3
Fisher Asset Management
Fisher Asset Management
Washington
+$17.2M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$16.3M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.2M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$23.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.7M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.7M
4
Morgan Stanley
Morgan Stanley
New York
-$8.99M
5
DTC
Deep Track Capital
Connecticut
-$5.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
DC
76
Diametric Capital
Massachusetts
$1.35M +$585K +15,122 +78%
Balyasny Asset Management
77
Balyasny Asset Management
Illinois
$1.32M -$11.7M -301,872 -90%
AG
78
Algert Global
California
$1.32M -$1.51M -39,112 -54%
AA
79
ALPS Advisors
Colorado
$1.27M -$100K -2,592 -7%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
80
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.19M +$68K +1,760 +6%
Prudential Financial
81
Prudential Financial
New Jersey
$1.17M +$259K +6,695 +29%
CSS
82
Cubist Systematic Strategies
Connecticut
$1.13M -$2.01M -52,089 -64%
EAM
83
Erste Asset Management
Austria
$1.13M – – –
VRS
84
Virginia Retirement Systems
Virginia
$1.12M +$1.11M +28,700 New
Victory Capital Management
85
Victory Capital Management
Texas
$1.08M +$827K +21,407 +344%
MIM
86
MetLife Investment Management
New Jersey
$1.06M – – –
Mirae Asset Global Investments
87
Mirae Asset Global Investments
South Korea
$1.03M +$387K +10,003 +61%
BFM
88
Boothbay Fund Management
New York
$1.03M +$1.02M +26,413 New
BPC
89
Banque Pictet & Cie
Switzerland
$1.03M +$1.02M +26,332 New
HSA
90
Hussman Strategic Advisors
Maryland
$1.02M – – –
FT
91
Fiduciary Trust
Massachusetts
$1.02M -$1.93K -50 -0.2%
PCM
92
Prelude Capital Management
New York
$983K +$5.14K +133 +0.5%
AIG
93
American International Group
New York
$968K +$13.5K +350 +1%
DekaBank Deutsche Girozentrale
94
DekaBank Deutsche Girozentrale
Germany
$868K – – –
TI
95
Trexquant Investment
Connecticut
$846K +$835K +21,594 New
Group One Trading
96
Group One Trading
Illinois
$841K +$252K +6,514 +44%
State Board of Administration of Florida Retirement System
97
State Board of Administration of Florida Retirement System
Florida
$829K – – –
UBS Group
98
UBS Group
Switzerland
$801K -$2.1M -54,292 -73%
VOYA Investment Management
99
VOYA Investment Management
Georgia
$787K -$2.31M -59,736 -75%
AQR Capital Management
100
AQR Capital Management
Connecticut
$759K -$1.48M -38,353 -66%
2 3
4
5 6

SAGE Hedge Fund Activity: Q3 2022 in Review

200 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2022, worth a combined $2.04B — up 24% from $1.65B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of SAGE and 23 opened new positions — a net loss of 7 holders — while 60 trimmed existing stakes and 68 added.

The largest buyer was Janus Henderson Group, adding an estimated $26.9M. The largest seller was Marshall Wace, cutting an estimated $23.7M.

  • 200 institutional investors held Sage Therapeutics (SAGE) as of Q3 2022, down from 209 in Q2 2022.
  • Funds reported $2.04B of Sage Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 23 funds opened new Sage Therapeutics positions in Q3 2022 and 30 closed out, a net change of -7 holders.
  • The largest Sage Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $26.9M added.
  • The largest Sage Therapeutics seller in Q3 2022 was Marshall Wace, an estimated $23.7M sold.

Based on aggregated 13F filings for Q3 2022.